Title AN OBSERVATIONAL COHORT STUDY USING SECONDARY DATA OF CARDIOVASCULAR RISK FACTORS (CVRF) CONTROL OF PATIENTS TREATED USING THE ACUTE MYOCARDIAL INFARCTION (AMI) PATHWAY IN CHANGI GENERAL HOSPITAL |
Type Free Paper Session 2 |
Theme ACC Asia & SCS 32nd Annual Scientific Meeting |
Topic Heart Failure / Cardiovascular Rehabilitation & Preventive Cardiology |
Main Author Daniel Fletcher1 |
Presenting Author Daniel Fletcher1 Nashirah Kamal Mustapa1 |
Co-Author Nashirah Kamal Mustapa1 Liew Boon Wah2 |
Department / Institution / Country Pharmacy / Changi General Hospital / Singapore1 Cardiology / Changi General Hospital / Singapore2 |
Objective(s) This study aims to compare the baseline CVRF values (at admission) and at first follow up (three months after discharge) of patients treated with the AMI pathway at CGH. |
Material and Method This is a quantitative study which used secondary data of patients’ CVRF under the AMI pathway at CGH. The patients’ information was accessed from the hospital’s in-house registry stored under the REDCap systems. Data extracted were from 1st January 2016 till 31st March 2017. Sunrise Clinical Manager (SCM) was used to access the patients CVRF data. CVRF which were ordinal variables such as blood pressure, low-density lipoprotein, glycosylated hemoglobin, weight, and body mass index were tabulated and analyzed using the Statistical Package for Social Science (SPSS) v.21.0 t-test while smoking status which is a nominal variable was tested using McNemar’s test. |
Result(s) A total of 691 suitable patients’ data was used in this study. The t-test analysis showed a significant reduction in all CVRF except for body mass index (p<0.001). Body mass index showed a numerical reduction however it did not achieve statistical significance (p=0.177). There was also a reduction in smokers in the post-intervention period (p<0.001). |
Conclusion The AMI pathway is capable of significantly reducing CVRF in post-AMI patients. Further monitoring of CVRF beyond three months is needed to validate its potential. |